| Date Filed | Type | Description |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Shanafelt Armen (10% Owner) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 12,000 options to buy
@ $4.35, valued at
$52.2k
|
|
| 06/10/2020 |
4
| Shanafelt Armen (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 28,100 options to buy
@ $8.89, valued at
$249.8k
|
|
| 10/03/2019 |
4
| Shanafelt Armen (10% Owner) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 16,531 options to buy
@ $1.17, valued at
$19.3k
|
|
| 06/07/2019 |
4
| Shanafelt Armen (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 12,400 options to buy
@ $6.33, valued at
$78.5k
|
|
| 06/06/2019 |
4
| Shanafelt Armen (10% Owner) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 12,100 options to buy
@ $3.69, valued at
$44.6k
|
|
| 06/25/2018 |
4
| Shanafelt Armen (Director) has filed a Form 4 on AILERON THERAPEUTICS INC|
Txns:
| Granted 10,000 options to buy
@ $6.02, valued at
$60.2k
|
|
| 06/12/2018 |
4
| Shanafelt Armen (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 12,000 options to buy
@ $6.98, valued at
$83.8k
|
|
| 06/08/2018 |
4
| Shanafelt Armen (10% Owner) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 18,400 options to buy
@ $10.28, valued at
$189.2k
|
|
| 04/23/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2018 |
3
| Shanafelt Armen (10% Owner) has filed a Form 3 on Surface Oncology, Inc. |
| 12/05/2017 |
4
| Shanafelt Armen (10% Owner) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.73, valued at
$141.9k
|
|
| 07/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2016 |
4
| Shanafelt Armen (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 24,000 options to buy
@ $12.88, valued at
$309.1k
|
|
| 08/16/2016 |
4
| Shanafelt Armen (10% Owner) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Converted 206,896 shares
@ $0
Converted 630,541 shares
@ $0
Converted 678,712 shares
@ $0
Bought 583,333 shares
@ $12, valued at
$7M
Converted 3,000,000 preferred shares
@ $0
Converted 9,142,857 preferred shares
@ $0
Converted 9,841,333 preferred shares
@ $0 |
|
| 08/10/2016 |
3
| Shanafelt Armen (10% Owner) has filed a Form 3 on Protagonist Therapeutics, Inc |
| 05/19/2016 |
4
| Shanafelt Armen (10% Owner) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 24,000 options to buy
@ $7.28, valued at
$174.7k
|
|
| 04/14/2016 |
4/A
| LILLY ELI & CO (10% Owner) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Converted 2,010,924 shares
@ $0 |
|
| 04/14/2016 |
3/A
| Form 3 - Initial statement of beneficial ownership of securities [amend] |
| 04/06/2016 |
3
| Lilly Ventures Fund I LLC (10% Owner) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |
| 04/06/2016 |
3
| Shanafelt Armen (10% Owner) has filed a Form 3 on Aeglea BioTherapeutics, Inc. |